A new treatment for women with hard-to-treat ovarian cancer has been approved for NHS use, offering a lifeline to hundreds of women.
This marks a significant advancement for patients whose disease has become resistant to chemotherapy, a condition often diagnosed at a late stage, making it particularly challenging to manage.
